| 000 | 01785 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250514004340.0 | ||
| 264 | 0 | _c20010830 | |
| 008 | 200108s 0 0 eng d | ||
| 022 | _a0021-9541 | ||
| 024 | 7 |
_a10.1002/jcp.1129 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aIdzko, M | |
| 245 | 0 | 0 |
_aFunctional characterization of P2Y and P2X receptors in human eosinophils. _h[electronic resource] |
| 260 |
_bJournal of cellular physiology _cSep 2001 |
||
| 300 |
_a329-36 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_a1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine _xanalogs & derivatives |
| 650 | 0 | 4 |
_aActins _xmetabolism |
| 650 | 0 | 4 |
_aCalcium _xmetabolism |
| 650 | 0 | 4 | _aCells, Cultured |
| 650 | 0 | 4 |
_aChelating Agents _xpharmacology |
| 650 | 0 | 4 |
_aChemotaxis _xdrug effects |
| 650 | 0 | 4 |
_aEgtazic Acid _xpharmacology |
| 650 | 0 | 4 |
_aEnzyme Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aEosinophils _xcytology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIntracellular Fluid _xmetabolism |
| 650 | 0 | 4 |
_aMacrophage-1 Antigen _xmetabolism |
| 650 | 0 | 4 |
_aNucleotides _xpharmacology |
| 650 | 0 | 4 | _aPertussis Toxin |
| 650 | 0 | 4 | _aPurinergic P2 Receptor Antagonists |
| 650 | 0 | 4 |
_aReceptors, Purinergic P2 _xclassification |
| 650 | 0 | 4 |
_aRespiratory Burst _xdrug effects |
| 650 | 0 | 4 |
_aUp-Regulation _xdrug effects |
| 650 | 0 | 4 |
_aVirulence Factors, Bordetella _xpharmacology |
| 700 | 1 | _aDichmann, S | |
| 700 | 1 | _aPanther, E | |
| 700 | 1 | _aFerrari, D | |
| 700 | 1 | _aHerouy, Y | |
| 700 | 1 | _aVirchow , C | |
| 700 | 1 | _aLuttmann, W | |
| 700 | 1 | _aDi Virgilio, F | |
| 700 | 1 | _aNorgauer, J | |
| 773 | 0 |
_tJournal of cellular physiology _gvol. 188 _gno. 3 _gp. 329-36 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/jcp.1129 _zAvailable from publisher's website |
| 999 |
_c11400795 _d11400795 |
||